| Primary |
| Renal Transplant |
12.5% |
| Immunosuppression |
11.7% |
| Prostate Cancer |
8.5% |
| Diffuse Large B-cell Lymphoma |
8.1% |
| Rheumatoid Arthritis |
7.0% |
| Immunosuppressant Drug Therapy |
5.8% |
| Acute Lymphocytic Leukaemia |
5.2% |
| Hypertension |
4.4% |
| Asthma |
4.2% |
| Colitis Ulcerative |
4.2% |
| Product Used For Unknown Indication |
4.1% |
| Systemic Lupus Erythematosus |
3.9% |
| Hodgkin's Disease |
2.9% |
| Crohn's Disease |
2.6% |
| Prostate Cancer Metastatic |
2.6% |
| Lymphoma |
2.6% |
| Prophylaxis |
2.6% |
| Pemphigus |
2.5% |
| Nephrotic Syndrome |
2.3% |
| Pain |
2.3% |
|
| Weight Increased |
15.7% |
| Vomiting |
7.8% |
| Drug Ineffective |
7.6% |
| Blood Glucose Increased |
6.2% |
| Osteonecrosis |
5.5% |
| Weight Decreased |
5.3% |
| Pneumonia |
4.6% |
| Sepsis |
4.4% |
| Neutropenia |
4.1% |
| Rash |
4.1% |
| Hyperglycaemia |
3.9% |
| Epidural Lipomatosis |
3.7% |
| Urinary Tract Infection |
3.7% |
| Lymphoma |
3.5% |
| Pyrexia |
3.5% |
| Vision Blurred |
3.5% |
| Diabetes Mellitus |
3.2% |
| Product Quality Issue |
3.2% |
| Respiratory Failure |
3.2% |
| Thrombocytopenia |
3.2% |
|
| Secondary |
| Diffuse Large B-cell Lymphoma |
19.0% |
| Product Used For Unknown Indication |
12.6% |
| Drug Use For Unknown Indication |
7.9% |
| Multiple Myeloma |
6.3% |
| B-cell Lymphoma |
5.9% |
| Non-hodgkin's Lymphoma |
5.5% |
| Hodgkin's Disease |
4.8% |
| Prophylaxis |
4.8% |
| Prostate Cancer |
4.8% |
| Rheumatoid Arthritis |
4.2% |
| Renal Transplant |
3.9% |
| Acute Lymphocytic Leukaemia |
3.9% |
| Hypertension |
3.5% |
| Lymphoma |
2.0% |
| Immunosuppression |
1.9% |
| Prostate Cancer Metastatic |
1.9% |
| Mantle Cell Lymphoma |
1.8% |
| Crohn's Disease |
1.8% |
| Pain |
1.8% |
| Prophylaxis Against Transplant Rejection |
1.8% |
|
| Sepsis |
8.0% |
| Vomiting |
7.8% |
| Febrile Neutropenia |
7.2% |
| Death |
7.1% |
| Pneumonia |
6.7% |
| Pyrexia |
6.0% |
| Weight Decreased |
5.9% |
| Weight Increased |
5.5% |
| Urinary Tract Infection |
5.3% |
| Thrombocytopenia |
4.8% |
| Neutropenia |
4.3% |
| White Blood Cell Count Decreased |
4.2% |
| Infection |
4.1% |
| Wound Dehiscence |
4.1% |
| Pulmonary Embolism |
3.9% |
| Respiratory Failure |
3.9% |
| Myelodysplastic Syndrome |
3.0% |
| Septic Shock |
2.9% |
| Transplant Rejection |
2.7% |
| Toxicity To Various Agents |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.9% |
| Rheumatoid Arthritis |
16.3% |
| Drug Use For Unknown Indication |
13.2% |
| Crohn's Disease |
7.5% |
| Pain |
4.2% |
| Hypertension |
4.1% |
| Asthma |
3.1% |
| Osteoporosis |
2.3% |
| Colitis Ulcerative |
2.0% |
| Depression |
1.9% |
| Prophylaxis |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Premedication |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Renal Transplant |
1.5% |
| Multiple Myeloma |
1.5% |
| Diabetes Mellitus |
1.3% |
| Arthritis |
1.3% |
| Anxiety |
1.1% |
| Vitamin Supplementation |
1.1% |
|
| Vomiting |
11.6% |
| Weight Decreased |
10.0% |
| Urinary Tract Infection |
5.9% |
| Pneumonia |
5.7% |
| Death |
5.7% |
| Pain |
5.4% |
| Weight Increased |
5.3% |
| Drug Ineffective |
5.3% |
| Pyrexia |
5.1% |
| Injection Site Pain |
4.6% |
| Rheumatoid Arthritis |
4.2% |
| Rash |
3.7% |
| Pain In Extremity |
3.6% |
| Urticaria |
3.6% |
| Thrombocytopenia |
3.6% |
| Pulmonary Embolism |
3.5% |
| Nausea |
3.5% |
| Crohn's Disease |
3.3% |
| Dyspnoea |
3.1% |
| Wheezing |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
24.7% |
| Drug Use For Unknown Indication |
15.2% |
| Rheumatoid Arthritis |
10.7% |
| Pain |
5.2% |
| Prophylaxis Against Transplant Rejection |
4.3% |
| Ankylosing Spondylitis |
3.7% |
| Uveitis |
3.7% |
| Smoking Cessation Therapy |
3.4% |
| Cardiac Disorder |
3.0% |
| Lymphoma |
3.0% |
| Osteoarthritis |
3.0% |
| Asthma |
2.7% |
| Hypertension |
2.4% |
| Pneumonia Bacterial |
2.4% |
| Psoriatic Arthropathy |
2.4% |
| Sinusitis |
2.4% |
| Atrial Fibrillation |
2.1% |
| Hiv Infection |
1.8% |
| Hypercalcaemia |
1.8% |
| Juvenile Arthritis |
1.8% |
|
| Drug Interaction |
29.6% |
| Respiratory Tract Infection |
7.0% |
| Psychomotor Hyperactivity |
5.6% |
| Psychotic Disorder |
5.6% |
| Weight Increased |
5.6% |
| Nausea |
4.2% |
| Rash |
4.2% |
| Renal Failure Acute |
4.2% |
| Sexual Dysfunction |
4.2% |
| Vomiting |
4.2% |
| Epilepsy |
2.8% |
| Gastrointestinal Inflammation |
2.8% |
| Loss Of Consciousness |
2.8% |
| Rhabdomyolysis |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Thrombocytopenia |
2.8% |
| Urinary Retention |
2.8% |
| Weight Decreased |
2.8% |
| Adverse Event |
1.4% |
| Bipolar Disorder |
1.4% |
|
